Ontario Health Study (OHS)
OHS is a population-based health study, with over 224,900 participants, serving as an integrated platform for researchers to investigate the environmental, lifestyle, clinical and genetic factors associated with risks of chronic diseases.

Ontario Tumour Bank (OTB)
OTB is a province-wide biorepository and data bankfocused on collection of tumour-related human biospecimens. It provides researchers with a diverse selection of high quality tumour-related specimens and derivatives accompanied with de-identified annotated clinical data.

Drug Discovery

Drug Discovery supports the synthesis and screening of small molecules, SAR analysis and hit triaging, a range of in vitro and in vivo assays to fully characterize ADME, pharmacokinetic profiles and maximum tolerated dose of candidates.

Genomics and Bioinformatics

Genomics and Bioinformatics is one of Ontario’s most advanced sequencing facilities, providing support throughout each stage of a research project, from initial project design to data analysis using one of Canada’s largest compute infrastructures.

Genome Informatics

Genome Informatics develops new software, databases, and other necessary components to store, organize and compute the large and complex datasets generated by OICR’s cancer research programs and other international programs. Our extensive data platforms are used worldwide for pioneer projects in cancer and pathogen genomics and human cohort data.

Centre for Imaging Technology Commercialization (CIMTEC)

CIMTEC provides imaging expertise and business development services such as image processing, 3D visualization, mechatronics design and systems that accelerate the development of imaging innovation and support licensing unique technologies.

Quantitative Imaging for Personalized Cancer Medicine (QIPCM)

QIPCM Institute focuses on the accelerated development and exploitation of technology for improved health by offering services and tools to support the acquisition of robust imaging data from multi-centre clinical trials.

Centre for Probe Development and Commercialization (CPDC)

CPDC works to discover, develop and distribute the next generation of imaging agents and targeted radiotherapeutics for the detection and treatment of human diseases, by offering probe development and characterization services, including radiopharmaceutical probes.

Imaging Validation Core (IVC)

IVC provides a means for validating novel in vivo imaging tools to improve the accuracy and capabilities of pathology and to facilitate the quantitative use of biomarkers for informing diagnostic and management decisions in cancer.

Diagnostic Development

Diagnostic Development focuses on the development of diagnostic assays and supports rapid implementation of precision medicine through a number of tissue-based research services.

Tissue Portal 

With human tissues at the core of most clinical cancer research, we offer a breadth of fee-based services helping researchers to get the most out of their material through our team known as Tissue Portal.